Get the Stockscreener App
46.76
4.24%
-2.07
After Hours:
46.95
0.19
+0.41%
Tempus Ai Inc stock is traded at $46.76, with a volume of 4.88M.
It is down -4.24% in the last 24 hours and down -12.94% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$48.83
Open:
$49.86
24h Volume:
4.88M
Relative Volume:
0.93
Market Cap:
$8.36B
Revenue:
$1.27B
Net Income/Loss:
$-245.03M
P/E Ratio:
-33.23
EPS:
-1.4071
Net Cash Flow:
$-245.36M
1W Performance:
-3.96%
1M Performance:
-12.94%
6M Performance:
-39.53%
1Y Performance:
-20.16%
1-Day Range:
$46.33
$50.75
1-Week Range:
$46.13
$50.75
52-Week Range:
$36.22
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
46.76 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
VEEV
Veeva Systems Inc
|
178.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
44.82 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.47 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.14 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares - Benzinga
Cathie Wood’s ARK trims Roku stock, buys Tempus AI - Investing.com
Tempus AI (NASDAQ:TEM) Trading Down 4.6%Time to Sell? - MarketBeat
Top Artificial Intelligence Stocks To Watch NowMarch 25th - MarketBeat
Ideas Watch: Is Tempus AI Inc stock risky to hold nowWeekly Gains Report & Verified Entry Point Detection - baoquankhu1.vn
Tempus Announces Strategic Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Clinical Differentiation Across an ADC Clinical Program - BioSpace
Tempus announces strategic collaboration with Daiichi Sankyo to advance AI-driven biomarker discovery and clinical differentiation across an ADC clinical program - marketscreener.com
Tempus Ai, Inc. and Daiichi Sankyo Enter Strategic Collaboration to Advance Ai-Driven Biomarker Discovery and Clinical Differentiation Across an Adc Clinical Program - marketscreener.com
Tempus AI partners with Daiichi Sankyo on cancer drug development - Investing.com
Artificial Intelligence Stocks To Watch TodayMarch 24th - MarketBeat
Thomas Edward Schoenherr Net Worth (2026) - GuruFocus
Tempus AI Inc. (TEM) touted as a buy amid focus on healthcare opportunities - MSN
Tempus AI Inc. (TEM) Touted as a Buy Amid Focus on Healthcare Opportunities - Insider Monkey
Promising Artificial Intelligence Stocks To Follow NowMarch 23rd - MarketBeat
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story - The Globe and Mail
Tempus AI’s diagnostic and data divisions Propel Sustainable Growth Over Time - Bitget
Best Artificial Intelligence Stocks Worth WatchingMarch 22nd - MarketBeat
Top Artificial Intelligence Stocks To ResearchMarch 21st - MarketBeat
Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape? - TradingView
Market Moves: What is the next catalyst for Tempus AI Inc2026 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
HC Wainwright raises Tempus AI (TEM) price target to $95 - MSN
H.C. Wainwright Raises Tempus AI (TEM) Price Target to $95 - Insider Monkey
Top Artificial Intelligence Stocks To ConsiderMarch 20th - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
10 Best New AI Stocks to Buy - Insider Monkey
Artificial Intelligence Stocks To ConsiderMarch 19th - MarketBeat
JPMorgan lowers Tempus AI (TEM) PT to $80, maintains neutral rating - MSN
Mizuho initiates coverage of Tempus AI (TEM) with outperform recommendation - MSN
3 MedTech stocks poised to gain in 2026 from the AI boom - MSN
Tempus AI Pediatric Leukemia Registry Deepens Oncology Data And Patient Reach - Yahoo Finance Singapore
Tempus AI, Inc. (TEM) announces strategic deal with Merck to fast-track AI-driven precision medicine - MSN
Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Weakness? - Yahoo Finance
Promising Artificial Intelligence Stocks To Keep An Eye OnMarch 17th - MarketBeat
Is Tempus AI (TEM) The Best AI Healthcare Stock in Cathie Wood’s Portfolio? - Insider Monkey
Tempus and Blood Cancer United announce collaboration to develop one of the largest pediatric acute myeloid leukemia Real-World Data registries - marketscreener.com
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries - The AI Journal
Best Artificial Intelligence Stocks To Add to Your WatchlistMarch 16th - MarketBeat
Tempus AI Advances Clinical Applications and Healthcare Software - TradingView
Bamco Inc. NY Increases Stake in Tempus AI, Inc. - National Today
Tempus AI, Inc. $TEM Shares Bought by Bamco Inc. NY - MarketBeat
Why Tempus AI, Inc. (TEM) Went Down On Wednesday - MSN
Cathie Wood buys $2 million of tumbling AI stock - MSN
Best Artificial Intelligence Stocks To Follow NowMarch 15th - MarketBeat
Clear Street Group Inc. Acquires Stake in Tempus AI - National Today
Casdin Capital LLC Purchases Shares of 294,127 Tempus AI, Inc. $TEM - MarketBeat
Clear Street Group Inc. Acquires Shares of 716,406 Tempus AI, Inc. $TEM - MarketBeat
Artificial Intelligence Stocks Worth WatchingMarch 14th - MarketBeat
Tempus AI falls despite Q4 beats, 2026 revenue guidance above consensus - MSN
Tempus AI price target lowered to $80 from $85 at JPMorgan - MSN
Tempus AI, Inc. $TEM Shares Acquired by Landscape Capital Management L.L.C. - MarketBeat
Tempus AI, Inc. Class A Trade Ideas — BX:TEM - TradingView
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.49%
1.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):